

CLASSIFICATION: GROWTH HORMONE RELEASING PEPTIDE
ACTIVE SUBSTANCE: GHRP-6
FORM: LYOPHILIZED POWDER (2 ML VIAL x 10 MG)
ACTIVE HALF-LIFE: APPROX. 30 MINUTES
DOSAGE: 100–300 MCG PER INJECTION (RESEARCH USE)
ACNE: POSSIBLE
WATER RETENTION: MILD
HIGH BLOOD PRESSURE (HBP): UNLIKELY
HEPATOTOXICITY: NONE
AROMATIZATION: NO
MANUFACTURER: PEPTIDE HUBS
GHRP-6 (Growth Hormone Releasing Peptide-6) is a synthetic hexapeptide designed to stimulate the body's natural growth hormone (GH) release while enhancing appetite through ghrelin receptor activation. The 10 mg format by Peptide Hubs provides a high concentration suitable for extended-duration protocols in metabolic and recovery-focused research.
GHRP-6 binds to the ghrelin receptor (GHS-R1a) in the hypothalamus and pituitary, triggering significant increases in GH secretion and hunger signals. This makes it highly valuable in preclinical models focused on muscle wasting, recovery from injury, appetite stimulation, and anabolic research. For detailed insights, review this NIH article on growth hormone secretagogues.
GHRP-6 is commonly studied in combination with CJC-1295 DAC to potentiate GH pulses, or GHK Basic to evaluate skin and tissue regeneration under GH influence.
Researchers often stack GHRP-6 with additional peptides for comprehensive anabolic and regenerative models:
GHRP-6 10 mg is offered strictly for **research purposes only**. It is not FDA-approved for human consumption. Although well-tolerated in research, some models show possible side effects like increased appetite, mild bloating, or transient prolactin elevation. It does not cause liver toxicity, aromatization, or androgenic side effects. For updates on its clinical relevance, visit ClinicalTrials.gov.
GHRP-6 10 mg is used in research to explore GH secretion, appetite stimulation, lean mass development, and muscle recovery in preclinical studies.
While both stimulate GH release, GHRP-6 produces a stronger appetite response than GHRP-2, making it more suitable for bulking or recovery-based research protocols.
Yes. GHRP-6 is frequently combined with CJC-1295 DAC to extend and amplify GH pulse effects, especially in studies targeting body composition and recovery.
No, GHRP-6 is not approved by the FDA and is sold for laboratory research use only. It should not be used in humans or animals outside research protocols.
Please log in to write GHRP-6 10 MG review.
CLASSIFICATION: GROWTH HORMONE SECRETAGOGUE
ACTIVE SUBSTANCE: IPAMORELIN
FORM: 2 ML VIAL (5 MG/VIAL)
ACTIVE HALF-LIFE: 2 HOURS
DOSAGE: 200–300 MCG 2–3 TIMES DAILY
ACNE: NOT REPORTED
WATER RETENTION: NOT REPORTED
HIGH BLOOD PRESSURE (HBP): NOT REPORTED
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: PEPTIDE HUBS
LABORATORY TESTED: VIEW LAB RESULTS
CLASSIFICATION: TISSUE REGENERATION PEPTIDE
ACTIVE SUBSTANCE: THYMOSIN BETA 4
FORM: 2 ML VIAL (5 MG/VIAL)
ACTIVE HALF-LIFE: ~ 2–3 HOURS
DOSAGE: 2–2.5 MG TWICE WEEKLY
ACNE: NOT REPORTED
WATER RETENTION: NOT REPORTED
HIGH BLOOD PRESSURE (HBP): NOT REPORTED
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: PEPTIDE HUBS
LABORATORY TESTED: VIEW LAB RESULTS
CLASSIFICATION: TISSUE REGENERATION PEPTIDE COMBINATION
ACTIVE SUBSTANCES:
- 5 MG THYMOSIN BETA 4
- 5 MG PENTADECAPEPTIDE
FORM: 2 ML VIAL (10 MG/VIAL TOTAL)
ACTIVE HALF-LIFE: ~ 2–6 HOURS
DOSAGE: 500–1000 MCG DAILY EACH
ACNE: NOT REPORTED
WATER RETENTION: NOT REPORTED
HIGH BLOOD PRESSURE (HBP): NOT REPORTED
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: PEPTIDE HUBS
LABORATORY TESTED: VIEW LAB RESULTS
CLASSIFICATION: HUMAN PEPTIDE HORMONE
ACTIVE SUBSTANCE: PENTADECAPEPTIDE
FORM: 2 ML VIAL (5 MG/VIAL)
ACTIVE HALF-LIFE: NOT APPLICABLE
DOSAGE: 250–500 MCG DAILY
ACNE: NOT REPORTED
WATER RETENTION: NOT REPORTED
HIGH BLOOD PRESSURE (HBP): NOT REPORTED
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: PEPTIDE HUBS
LABORATORY TESTED: VIEW LAB RESULTS
CLASSIFICATION: MELANOCORTIN PEPTIDE ANALOG
ACTIVE SUBSTANCE: MELANOTAN 2
FORM: 2 ML VIAL (10 MG/VIAL)
ACTIVE HALF-LIFE: ~ 33 HOURS
DOSAGE: 250–500 MCG DAILY
ACNE: POSSIBLE
WATER RETENTION: NOT REPORTED
HIGH BLOOD PRESSURE (HBP): NOT REPORTED
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: PEPTIDE HUBS
LABORATORY TESTED: VIEW LAB RESULTS
CLASSIFICATION: GROWTH HORMONE SECRETAGOGUE (GHRH ANALOG)
ACTIVE SUBSTANCE: TESAMORELIN
FORM: 2 ML VIAL (5 MG/VIAL)
ACTIVE HALF-LIFE: APPROXIMATELY 30 MINUTES
DOSAGE: 1–2 MG DAILY
ACNE: POSSIBLE
WATER RETENTION: POSSIBLE
HIGH BLOOD PRESSURE (HBP): NOT REPORTED
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: PEPTIDE HUBS
CLASSIFICATION: GROWTH HORMONE SECRETAGOGUE (GHRH ANALOG)
ACTIVE SUBSTANCE: SERMORELIN
FORM: 2 ML VIAL (5 MG/VIAL)
ACTIVE HALF-LIFE: ~ 11–12 MINUTES
DOSAGE: 100–300 MCG DAILY
ACNE: NOT REPORTED
WATER RETENTION: POSSIBLE
HIGH BLOOD PRESSURE (HBP): NOT REPORTED
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: PEPTIDE HUBS
CLASSIFICATION: NOOTROPIC PEPTIDE
ACTIVE SUBSTANCE: SEMAX
FORM: 2 ML VIAL (30 MG/VIAL)
ACTIVE HALF-LIFE: ~ 4–5 HOURS
DOSAGE: 200–500 MCG ONCE OR TWICE DAILY
ACNE: NOT REPORTED
WATER RETENTION: NOT REPORTED
HIGH BLOOD PRESSURE (HBP): NOT REPORTED
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: PEPTIDE HUBS